about
Screening Chemicals for Receptor-Mediated Toxicological and Pharmacological Endpoints: Using Public Data to Build Screening Tools within a KNIME Workflow.Protective role of retinoid X receptor in H9c2 cardiomyocytes from hypoxia/reoxygenation injury in rats.Ligand Dependent Switch from RXR Homo- to RXR-NURR1 Heterodimerization.Interaction between gut microbiota and toll-like receptor: from immunity to metabolismThe multi-faceted role of retinoid X receptor in bone remodeling.Identification of functionally relevant lysine residues that modulate human farnesoid X receptor activation.Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease.Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment.
P2860
Q30489654-C1E00425-84D4-4048-9086-52A3EAA6D8C6Q34032392-0B2C3CF0-D870-4BF9-8E69-5C434EA3F8ECQ38686743-AF9B09C6-4CEA-420B-BE02-054BE76831A4Q38957575-0CBCDF68-B773-4B38-9F78-3C1C9D3E34E4Q39096039-EA4EB498-3ED6-4F3F-A606-62B5752006FAQ41943299-BBA9F4BB-3A0A-487D-A8E4-7D88BB7FA41AQ42291314-841882C6-676F-447D-97FC-FF1F3EFEAF7CQ48291937-924DC4F4-C02B-45DC-9D55-D78C53679D36
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Advances in drug design with RXR modulators
@ast
Advances in drug design with RXR modulators
@en
Advances in drug design with RXR modulators
@nl
type
label
Advances in drug design with RXR modulators
@ast
Advances in drug design with RXR modulators
@en
Advances in drug design with RXR modulators
@nl
prefLabel
Advances in drug design with RXR modulators
@ast
Advances in drug design with RXR modulators
@en
Advances in drug design with RXR modulators
@nl
P2860
P1476
Advances in drug design with RXR modulators
@en
P2093
Ángel R de Lera
P2860
P304
P356
10.1517/17460441.2012.722992
P407
P577
2012-11-01T00:00:00Z